This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for February 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Implied Volatility Surging for Aurora Cannabis (ACB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $2.12, marking a -0.93% move from the previous day.
Will Aurora Cannabis Inc. (ACB) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aurora Cannabis Inc. (ACB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $1.94, moving +0.52% from the previous trading session.
What's in Store for Pot Stocks This Year?
by Nitish Marwah
Increasing tolerance, financial protection, credit availability and legal votes have shaped America's hemp industry lately.
Aurora Cannabis Inc. (ACB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $2.07, marking a +1.47% move from the previous day.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $2.13, moving -0.93% from the previous trading session.
Is the Options Market Predicting a Spike in Aurora Cannabis (ACB) Stock?
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $2, marking a -0.99% move from the previous day.
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
by Sanghamitra Saha
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
Company News For Dec 24, 2019
by Zacks Equity Research
Companies in the news are: ACB, APA, ITCI, SRPT
5 Cheap Stocks Trading Under $20 to Buy for 2020
by Benjamin Rains
Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $2.25, moving -0.88% from the previous trading session.
Corporate News for Dec 19, 2019
by Zacks Equity Research
Companies In The News Are:
Is REX Shares' Leveraged Cannabis ETN Launch Untimely?
by Sanghamitra Saha
REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?
Options Traders Expect Huge Moves in Aurora (ACB) Stock
by Zacks Equity Research
Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
Company News For Nov 21, 2019
by Zacks Equity Research
Companies in the news are: URBN, KNSA, ACB, ENDP
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Options Traders Expect Huge Moves in Aurora (ACB) Stock
by Zacks Equity Research
Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.
Why Marijuana Stocks Plummeted in 2019
by Madeleine Johnson
Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?
Aurora Cannabis Inc. (ACB) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 133.33% and -21.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Aurora Cannabis (ACB) in Q1 Earnings?
by Zacks Equity Research
Aurora Cannabis' (ACB) Q1 earnings are likely to reflect cannabis revenue growth and improved gross margin.